Who
Daniel Virnich
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, The Oncology Institute.
In numbers
- Trades disclosed
- 41
- Buys
- 1
- Sells
- 1
- Bought
- $24K
- Sold
- $7,647
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Nov 2021
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $103K23,058 at $4.47 | filing |
| 21 May 2026filed 22 May 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $103K23,058 at $4.47 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —670,608 at $0.00 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $302K98,534 at $3.07 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —670,608 at $0.00 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $302K98,534 at $3.07 | filing |
| 17 Mar 2026filed 18 Mar 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $42K11,834 at $3.59 | filing |
| 17 Mar 2026filed 18 Mar 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $42K11,834 at $3.59 | filing |
| 17 Nov 2025filed 19 Nov 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —6,464 at $0.00 | filing |
| 12 Nov 2025filed 14 Nov 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —6,211 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $55K20,388 at $2.68 | filing |
| 31 Mar 2025filed 2 Apr 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —1,083,334 at $0.00 | filing |
| 26 Mar 2025filed 28 Mar 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code P | $1,47211,320 at $0.13 | filing |
| 26 Mar 2025filed 28 Mar 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $24K22,640 at $1.04 | filing |
| 19 Mar 2025filed 20 Mar 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $9,13210,261 at $0.89 | filing |
| 20 Nov 2024filed 21 Nov 2024 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $6654,750 at $0.14 | filing |
| 20 Nov 2024filed 21 Nov 2024 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $6974,977 at $0.14 | filing |
| 12 Nov 2024filed 18 Nov 2024 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | —78,094 at $0.00 | filing |
| 12 Nov 2024filed 18 Nov 2024 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | —117,142 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —496,293 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.